I wouldn't rely on Morningstar's valuations for any stock but hey that's just my opinion ..... nothing much will happen with the Mesoblast share price IMO until something of real substance is announced .... be that AA for sr-GVHD for <12 yo's; very positive Type A meeting; CLBP partnership and / or trial start; CHF FDA meeting information; UC / Crohn's disease trial readouts; takeover bid; etc etc etc etc etc
..... until then I would temper my expectations re: the share price ... I personally don't expect any 'real' news now until next quarter
2023 The Final Countdown, page-3309
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
0.105(7.64%) |
Mkt cap ! $1.689B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.49 | $1.38 | $8.181M | 5.685M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25443 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 60811 | 4 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |